Dosage judgment and administration safety

The manuals converge on the need for careful dose judgement rather than formulaic escalation. Across 5-MeO-DMT, ibogaine, LSD, and ayahuasca, the sources emphasise that dose depends on the material, the person, and the setting or protocol, and that facilitators need to know what is being administered, in what form, and with what expected effect. They also share a concern with safety in administration, whether that means accounting for purity and batch variation, waiting for vitals and withdrawal status to be appropriate, or understanding the approximate alkaloid content of a brew. The sources also agree that dosing is not just about the first amount given, but about judgement around follow-up dosing and monitoring. The ibogaine and LSD manuals both mention booster doses, while the ibogaine text adds test doses and objective withdrawal measures. The LSD handbook and the 5-MeO-DMT guidance both caution against using small-dose escalation as a substitute for discernment, although they frame this in different contexts. The manuals differ in how specific and procedural they are. The LSD handbook is the most explicit about administration errors, including liquid preparation, one dose at a time, and the possibility that liver damage may affect responsiveness. The ibogaine guidance is more medically oriented, focusing on patient condition, risk factors, hydration, and withdrawal severity.